Skip to main content

Immunovant, Inc.

IMVT
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001764013

In the last 90 days, Immunovant, Inc. insiders filed 0 open-market purchases and 10 sales; 226 institutions reported holding it in 13F filings for Q2 2026, worth $4.25B in total; Greenlight Capital is the only superinvestor holding it.

13F holders, Q2 2026

Institutional positions in Immunovant, Inc. as of Jun 30, 2026. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
226
+14 vs. Q1 2026
Shares held
110.4M
−172.0K (−0.2%) vs. Q1 2026
Total value
$4.25B
+$1.51B (+54.8%) vs. Q1 2026
New holders
38
74 more added
Sold out
24
79 more reduced

4 institutions that held it in Q1 2026 haven't filed for Q2 2026 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.

Compare with Q1 2026: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting IMVT on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2026: 226 institutions
Q1 2021: 120 institutionsQ2 2021: 110 institutionsQ3 2021: 119 institutionsQ4 2021: 118 institutionsQ1 2022: 112 institutionsQ2 2022: 94 institutionsQ3 2022: 112 institutionsQ4 2022: 133 institutionsQ1 2023: 142 institutionsQ2 2023: 147 institutionsQ3 2023: 181 institutionsQ4 2023: 228 institutionsQ1 2024: 209 institutionsQ2 2024: 197 institutionsQ3 2024: 182 institutionsQ4 2024: 187 institutionsQ1 2025: 194 institutionsQ2 2025: 169 institutionsQ3 2025: 186 institutionsQ4 2025: 197 institutionsQ1 2026: 216 institutionsQ2 2026: 226 institutions
Value heldQ2 2026: $4.25B
Q1 2021: $654.3MQ2 2021: $407.5MQ3 2021: $293.6MQ4 2021: $322.4MQ1 2022: $218.6MQ2 2022: $156.5MQ3 2022: $238.1MQ4 2022: $1.00BQ1 2023: $903.7MQ2 2023: $1.05BQ3 2023: $2.57BQ4 2023: $2.88BQ1 2024: $2.27BQ2 2024: $1.97BQ3 2024: $2.26BQ4 2024: $1.98BQ1 2025: $1.62BQ2 2025: $1.54BQ3 2025: $1.53BQ4 2025: $2.76BQ1 2026: $2.75BQ2 2026: $4.25B
Institutions holding IMVT and their total value by quarter
QuarterHoldersValue
Q2 2026226$4.25B
Q1 2026216$2.75B
Q4 2025197$2.76B
Q3 2025186$1.53B
Q2 2025169$1.54B
Q1 2025194$1.62B
Q4 2024187$1.98B
Q3 2024182$2.26B
Q2 2024197$1.97B
Q1 2024209$2.27B
Q4 2023228$2.88B
Q3 2023181$2.57B
Q2 2023147$1.05B
Q1 2023142$903.7M
Q4 2022133$1.00B
Q3 2022112$238.1M
Q2 202294$156.5M
Q1 2022112$218.6M
Q4 2021118$322.4M
Q3 2021119$293.6M
Q2 2021110$407.5M
Q1 2021120$654.3M

Institutions, Q2 2026

Shares, value and share of portfolio for each institution holding Immunovant, Inc.; share changes are against Q1 2026.

Institutions holding IMVT in Q2 2026
InstitutionSharesValue% of portfolioChange in sharesAction
Standard Life Aberdeen plc857,030$33.0M0.05%−303,732−26.2%Reduced
Susquehanna International Group, LLP1,022,513$39.4M0.03%+404,706+65.5%Added
Bank of America Corp1,181,452$45.5M0.00%+287,774+32.2%Added
D. E. Shaw & Co., Inc.1,240,654$47.8M0.03%+1,240,654New
Perceptive Advisors LLC1,357,383$52.3M0.81%−240,000−15.0%Reduced
Alpine Global Management, LLC1,375,000$53.0M8.72%−1,261,925−47.9%Reduced
Armistice Capital, LLC1,736,000$66.9M1.85%−1,828,916−51.3%Reduced
Goldman Sachs Group Inc1,751,183$67.5M0.01%−33,924−1.9%Reduced
Price T Rowe Associates Inc1,829,210$70.5M0.01%+1,489,603+438.6%Added
Woodline Partners LP1,975,869$76.1M0.24%00.0%Unchanged
T. Rowe Price Investment Management, Inc.2,222,101$85.6M0.06%−1,390,759−38.5%Reduced
Geode Capital Management, LLC2,234,602$86.1M0.00%+142,500+6.8%Added
ADAR1 Capital Management, LLC2,330,716$89.8M4.22%−348,294−13.0%Reduced
Two Seas Capital LP3,148,505$121.3M4.63%−53,457−1.7%Reduced
RTW Investments, LP3,177,849$122.4M1.05%00.0%Unchanged
Jennison Associates LLC3,310,238$127.5M0.08%+113,533+3.6%Added
Vanguard Capital Management LLC3,638,681$140.2M0.00%+18,631+0.5%Added
Vanguard Portfolio Management LLC3,910,509$150.7M0.01%+205,604+5.5%Added
TCG Crossover Management, LLC4,457,988$171.8M4.13%00.0%Unchanged
Morgan Stanley4,534,833$174.7M0.01%+657,956+17.0%Added
State Street Corp4,617,005$177.9M0.01%+79,076+1.7%Added
Baker Bros. Advisors LP5,435,220$209.4M1.05%−22,661−0.4%Reduced
Farallon Capital Management, L.L.C.5,805,000$223.7M1.31%+4,259,000+275.5%Added
BlackRock, Inc.7,180,897$276.7M0.00%+606,400+9.2%Added
Deep Track Capital, LP9,341,151$359.9M5.30%−2,185,820−19.0%Reduced
FMR LLC16,186,469$623.7M0.03%−761,419−4.5%Reduced
Candriam Luxembourg S.C.A.0$00.00%−680,372−100.0%Sold out
Great Point Partners LLC0$00.00%−545,625−100.0%Sold out
Trails Edge Capital Partners, LP0$00.00%−414,054−100.0%Sold out
Adage Capital Partners GP, L.L.C.0$00.00%−413,000−100.0%Sold out
Prosight Management, LP0$00.00%−175,825−100.0%Sold out
Blackstone Group Inc.0$00.00%−107,297−100.0%Sold out
Jane Street Group, LLC0$00.00%−84,312−100.0%Sold out
ArrowMark Colorado Holdings LLC0$00.00%−70,000−100.0%Sold out
Schonfeld Strategic Advisors LLC0$00.00%−33,553−100.0%Sold out
Ellsworth Advisors, LLC0$00.00%−32,280−100.0%Sold out
LMR Partners LLP0$00.00%−26,045−100.0%Sold out
Inceptionr LLC0$00.00%−24,272−100.0%Sold out
ExodusPoint Capital Management, LP0$00.00%−21,941−100.0%Sold out
Group One Trading, L.P.0$00.00%−20,586−100.0%Sold out
Hudson Bay Capital Management LP0$00.00%−19,230−100.0%Sold out
Nomura Holdings Inc0$00.00%−16,011−100.0%Sold out
Marex Group plc0$00.00%−16,000−100.0%Sold out
Oxford Asset Management LLP0$00.00%−12,456−100.0%Sold out
Westfield Capital Management Co LP0$00.00%−8,581−100.0%Sold out
Quadrant Capital Group LLC0$00.00%−212−100.0%Sold out
MAI Capital Management0$00.00%−20−100.0%Sold out
First Command Advisory Services, Inc.0$00.00%−10−100.0%Sold out
Advisory Services Network, LLC0$00.00%−9−100.0%Sold out
Twin Peaks Wealth Advisors, LLC0$00.00%−3−100.0%Sold out
Deeter Investments LLP––––Not filed
Janus Henderson Group PLC––––Not filed
CWM, LLC––––Not filed
Red Tortoise LLC––––Not filed